| SYS | | r033528 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130617162244.7 |
|---|
| 100 | | $a 20050524a2005 m y0sloc0103 ba |
|---|
| 101 | 0- | $a slo |
|---|
| 102 | | $a CZ |
|---|
| 200 | 1- | $a Regresia elektrokardiograficky diagnostikovanej hypertrofie ľavej komory počas antihypertenznej liečby a predikcia závažných kardiovaskulárnych príhod $d Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events $f Peter M. Okin ... [et al.] |
|---|
| 215 | | $c Obr., tab. |
|---|
| 305 | | $a JAMA 2004; 292: 2343-2349 |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000115_2005_005_005 $1 011 $a 1210-4132 $1 200 1 $a JAMA $e české a slovenské vydání $v Roč. 13, č. 5 (2005), s. 297-303 $1 210 $a Praha $c Praha Publishing |
|---|
| 510 | 1- | $a Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events $z eng |
|---|
| 606 | 1- | $a hypertrofia ľavej komory $x diagnostika $x patológia $x terapia $2 mesh $3 sllk_un_auth*d017379 $9 . |
|---|
| 606 | 1- | $a echokardiografia $x využitie $2 mesh $3 sllk_un_auth*d004452 $9 . |
|---|
| 606 | 1- | $3 sllk_un_auth*d000959 $a antihypertenzíva $x aplikácia a dávkovanie $x použitie terapeutické $9 . $2 mesh |
|---|
| 606 | 2- | $a remisia spontánna $2 mesh $3 sllk_un_auth*d012075 $9 . |
|---|
| 606 | 2- | $a predispozícia k chorobe, genetická $x prevencia a kontrola $2 mesh $3 sllk_un_auth*d020022 $9 . |
|---|
| 675 | | $a 616.124.2-007.61:615.225.2 $v 2. $z slo |
|---|
| 701 | -1 | $a Okin $b Peter M. $3 sllk_un_auth*p0002282 $4 070 $p Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York |
|---|
| 701 | -1 | $a Devereux $b R.B. $g Richard B. $3 sllk_un_auth*p0031515 $4 070 $p Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York |
|---|
| 701 | -1 | $a Jern $b Sverker $3 sllk_un_auth*p0041439 $4 070 $p Sahlgrenska University Hospital/Östra, Göteborg, Švédsko |
|---|
| 701 | -1 | $a Kjeldsen $b Sverre E. $3 sllk_un_auth*p0041440 $4 070 $p Ulleväl University Hospital, Oslo, Nórsko |
|---|
| 701 | -1 | $a Julius $b Stevo $3 sllk_un_auth*p0022337 $4 070 $p Division of Hypertension, University of Michigan Medical Center, Ann Arbor, Michigan, USA |
|---|
| 701 | -1 | $a Nieminen $b Markku S. $3 sllk_un_auth*p0041441 $4 070 $p Division of Cardiology, Department of Medicine, Helsinki University, Helsinki, Fínsko |
|---|
| 701 | -1 | $a Snapinn $b Steven $3 sllk_un_auth*p0041442 $4 070 $p Amgen Inc, Thousand Oaks, Calif |
|---|
| 701 | -1 | $a Harris $b Katherine E. $3 sllk_un_auth*p0041443 $4 070 $p Merck Research Laboratories, West Point, Pa |
|---|
| 701 | -1 | $a Aurup $b Peter $3 sllk_un_auth*p0041444 $4 070 $p Merck Research Laboratories, West Point, Pa |
|---|
| 701 | -1 | $a Edelman $b Jonathan M. $3 sllk_un_auth*p0041445 $4 070 $p Merck & Co Inc, Whitehouse Station, New Jersey |
|---|
| 701 | -1 | $a Wedel $b H. $g Hans $3 sllk_un_auth*p0065389 $4 070 $p Nordic School of Public Health, Göteborg, Švédsko |
|---|
| 701 | -1 | $a Lindholm $b Lars H. $3 sllk_un_auth*p0041446 $4 070 $p Umeä University, Umeä, Švédsko |
|---|
| 701 | -1 | $a Dahlöf $b Björn $3 sllk_un_auth*p0041447 $4 070 $p Sahlgrenska University Hospital/Östra, Göteborg, Švédsko |
|---|
| 701 | -1 | $a Trenkler $b Štefan $3 sllk_un_auth*p0064366 $4 730 $p II. klinika anestéziológie a intenzívnej medicíny SZU a PU FNsP, Prešov |
|---|
| 801 | -0 | $a SK $b BA006 $c 20050524 $g AACR2 |
|---|
